SCHEMBL24933706

SCHEMBL24933706

Cc1cc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)cc(C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
HDAC3 O15379 2/20 0.38
PARP1 P09874 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
HSD17B1 P14061 5/20 0.38
HSD17B2 P37059 5/20 0.38
MAOB P27338 3/20 0.38
PPARD Q03181 2/20 0.37
PPARA Q07869 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933809 0.90 HSD17B1 (0.38) CDK5CDK5R1HDAC3PARP1HDAC4
SCHEMBL24933369 0.88 HSD17B1 (0.38) PARP10CDK5CDK5R1PARP1HDAC1
SCHEMBL30240787 0.88 HSD17B1 (0.38) PARP10CDK5CDK5R1PARP1HDAC1
SCHEMBL24933637 0.86 MAOB (0.44) PARP10HDAC3PARP1HDAC4HDAC1
SCHEMBL24933646 0.86 MAOB (0.44) PARP10CDK5CDK5R1HDAC3PARP1
SCHEMBL24933349 0.86 GSTP1 (0.50) PARP10HSD17B1HSD17B2MAOBDHODH
SCHEMBL24933267 0.86 HSD17B1 (0.40) PARP10CDK5CDK5R1HDAC3PARP1
SCHEMBL24933881 0.86 HSD17B1 (0.38) CDK5CDK5R1HDAC3PARP1HDAC4
SCHEMBL30240745 0.86 HSD17B1 (0.40) PARP10CDK5CDK5R1HDAC3PARP1
SCHEMBL24933385 0.85 PARP1 (0.39) PARP10HDAC3PARP1HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed